Victoza Sales Data
|Rank 60||Current sales rank, all
Last updated: May 2013 (updated quarterly).
The following data shows Victoza U.S. retail sales in Q1 2013 compared to previous quarters.
|Date Range||Sales Rank||Sales ($000)||Units (000)|
|Q1 2013||60 (8)||$242,143||6.43%||607||9.76%|
|Q4 2012||68 (6)||$227,520||8.78%||553||7.17%|
|Q3 2012||74 (24)||$209,163||27.22%||516||18.08%|
|Q2 2012||98 ()||$164,409||437|
* Units refer to the number of packages sold.
|April 20, 2012||Statement From Novo Nordisk Regarding the Petition to the FDA By Public Citizen|
|February 18, 2010||FDA Approved Diabetes Drug Despite Hints at Cancer Risk|
|January 26, 2010||Victoza Sanctioned for Type 2 Diabetes|